Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
8.34
+0.18 (2.21%)
Dec 26, 2025, 4:00 PM EST - Market closed
Cybin Market Cap
Cybin has a market cap or net worth of $416.2 million as of December 26, 2025. Its market cap has increased by 101.63% in one year.
Market Cap
416.20M
Enterprise Value
361.33M
1-Year Change
101.63%
Ranking
Category
Stock Price
$8.34
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $416.20M, an increase of 356.88%. That is a compound annual growth rate of 34.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 416.20M | 135.92% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | 195.64M | 114.76% |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |